A Randomized Trial of an Acid-peptic Disease Management Program in a Managed Care EnvironmentByJoshua J. Ofman, MD,Richard Segal, PhD,Wayne L. Russell, PharmD,Deborah J. Cook, MD, MSc,Meenu Sandhu, MS,Susan K. Maue, PhD,Edward H.June 1st 2003
When Money Is Saved by Reducing Healthcare Costs, Where Do US Primary Care Physicians Think the Money Goes?ByDavid A. Asch, MD, MBA,Christopher Jepson, PhD,John C. Hershey, PhD,Jonathan Baron, PhD,Peter A. Ubel, MDJune 1st 2003
Care Management Interventions for Older Patients with Congestive Heart FailureByB. Gwen Windham, MD,Richard G. Bennett, MD,Sheldon Gottlieb, MDJune 1st 2003
High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) TrialByJ. Sanford Schwartz, MD,Y. Richard Wang, MD, PhD,John G. F. Cleland, MD,Longlong Gao, MS,Mark Weiner, MD,Philip A. Poole-Wilson, MD,foJune 1st 2003
